FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

28791411000001105: Cyramza 100mg/10ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) 1 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Mar 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
90061101000001112 Cyramza 100mg/10ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) 1 vial (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
90061201000001117 Cyramza 100mg/10ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) 1 vial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cyramza 100mg/10ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cyramza 100mg/10ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) 1 vial Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cyramza 100mg/10ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Cyramza 100mg/10ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) 1 vial Is a Ramucirumab 100mg/10ml solution for infusion vials 1 vial true Inferred relationship Existential restriction modifier
Cyramza 100mg/10ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) 1 vial Has AMP Cyramza 100mg/10ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) true Inferred relationship Existential restriction modifier
Cyramza 100mg/10ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) 1 vial Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Cyramza 100mg/10ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) 1 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cyramza 100mg/10ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) 1 vial VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cyramza 100mg/10ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) 1 vial Has specific active ingredient Ramucirumab false Inferred relationship Existential restriction modifier
Cyramza 100mg/10ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) 1 vial Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Cyramza 100mg/10ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) 1 vial Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Cyramza 100mg/10ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) 1 vial Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Cyramza 100mg/10ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) 1 vial Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Cyramza 100mg/10ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) 1 vial Has specific active ingredient Ramucirumab true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start